je.st
news
FDA Advisory Committee Recommends The Approval Of Lesinurad For Gout Patients
2015-11-03 04:41:07| drugdiscoveryonline Home Page
AstraZeneca recentlyannounced that the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee (AAC) voted 10-4 to recommend the approval of lesinurad 200 mg tablets for the treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor (XOI)
Tags: committee
approval
patients
advisory
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||